Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CNSP CNS Pharmaceuticals Inc

0,0969

0,0007 (0,73%)

Zuletzt aktualisiert: 21:13:58

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

CNS Pharmaceuticals (NASDAQ:CNSP)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more CNS Pharmaceuticals Charts.

CNS Pharmaceuticals (NASDAQ:CNSP)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more CNS Pharmaceuticals Charts.

News CNS Pharmaceuticals Inc

Form 8-K - Current report
Mittwoch 11 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEFR14A - Revised definitive proxy soliciting materials
Freitag 15 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 1 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Montag 28 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 24 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Donnerstag 24 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 23 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Dienstag 15 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 18 September 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 12 September 2024 (5 Monate vor) • Edgar (US Regulatory)

IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
Dienstag 3 September 2024 (5 Monate vor) • GlobeNewswire Inc.

Weitere CNS Pharmaceuticals Inc News-Artikel

Financial Select Sector

Gold vs US Dollar

Deutsche Lufthansa

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen